Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients
Clinical trial NCT04421352 · COMPLETED
Trial details
- NCT number
- NCT04421352
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-12
- Primary completion
- 2023-12-22
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.